Trial
NCT00927784
Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
National Heart, Lung, and Blood Institute (NHLBI); Angioblast Systems
Condition
Heart Failure
Intervention
Mesenchymal Precursor cells (RevascorTM)
Why stopped
The enrollment has been terminated by the NHLBI for administrative reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-03-05